Geode Capital Management LLC Grows Stake in ASP Isotopes Inc. (NASDAQ:ASPI)

Geode Capital Management LLC grew its holdings in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,175,450 shares of the company's stock after buying an additional 57,027 shares during the quarter. Geode Capital Management LLC owned 1.65% of ASP Isotopes worth $5,326,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ASPI. Diametric Capital LP increased its stake in shares of ASP Isotopes by 4.1% in the 4th quarter. Diametric Capital LP now owns 303,855 shares of the company's stock valued at $1,376,000 after buying an additional 11,886 shares during the period. Paragon Associates & Paragon Associates II Joint Venture bought a new position in shares of ASP Isotopes during the fourth quarter worth about $113,000. JPMorgan Chase & Co. grew its holdings in ASP Isotopes by 854.6% during the fourth quarter. JPMorgan Chase & Co. now owns 211,893 shares of the company's stock worth $960,000 after purchasing an additional 189,697 shares during the period. Rovida Investment Management Ltd acquired a new position in ASP Isotopes in the 4th quarter valued at about $990,000. Finally, LPL Financial LLC acquired a new stake in ASP Isotopes during the 4th quarter worth approximately $54,000. 16.80% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Paul Elliot Mann sold 316,667 shares of the business's stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total value of $1,820,835.25. Following the completion of the transaction, the chief executive officer now owns 7,948,787 shares of the company's stock, valued at $45,705,525.25. The trade was a 3.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Robert Ainscow sold 66,668 shares of the stock in a transaction that occurred on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total transaction of $374,674.16. Following the sale, the chief operating officer now owns 1,419,992 shares in the company, valued at $7,980,355.04. This represents a 4.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 766,667 shares of company stock valued at $4,358,502 over the last 90 days. 21.40% of the stock is owned by corporate insiders.

ASP Isotopes Stock Performance

Shares of ASPI stock traded up $0.23 on Thursday, hitting $5.51. The company's stock had a trading volume of 556,154 shares, compared to its average volume of 2,348,308. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The stock's 50 day moving average is $4.78 and its 200-day moving average is $5.31. The company has a market capitalization of $396.73 million, a PE ratio of -9.02 and a beta of 3.44. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.